companydirectorylist.com  Global Business Directories and Company Directories
Search Business,Company,Industry :


Country Lists
USA Company Directories
Canada Business Lists
Australia Business Directories
France Company Lists
Italy Company Lists
Spain Company Directories
Switzerland Business Lists
Austria Company Directories
Belgium Business Directories
Hong Kong Company Lists
China Business Lists
Taiwan Company Lists
United Arab Emirates Company Directories


Industry Catalogs
USA Industry Directories












Company Directories & Business Directories

JANSSEN COSMECEUTICAL CARE; LLC

FOOTHILL RANCH-USA

Company Name:
Corporate Name:
JANSSEN COSMECEUTICAL CARE; LLC
Company Title:  
Company Description:  
Keywords to Search:  
Company Address: 2102 Business Centre Drive #180 D,FOOTHILL RANCH,CA,USA 
ZIP Code:
Postal Code:
92610 
Telephone Number:  
Fax Number:  
Website:
 
Email:
 
USA SIC Code(Standard Industrial Classification Code):
738999 
USA SIC Description:
Business Services Nec 
Number of Employees:
 
Sales Amount:
 
Credit History:
Credit Report:
 
Contact Person:
 
Remove my name



copy and paste this google map to your website or blog!

Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples:
WordPress Example, Blogger Example)









Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer

(Any information to deal,buy, sell, quote for products or service)

Your Subject:
Your Comment or Review:
Security Code:



Previous company profile:
SOLOMON GALT NETWORKS
SPECTRUM CARE
YOGA PATH
Next company profile:
ONEAL COMMUNICATIONS GROUP
PALADIN CAPITAL PARTNERS
SPILLWATER PRODUCTIONS










Company News:
  • Janssen
    We would like to show you a description here but the site won’t allow us
  • Home Fact Group | Janssen
    “At Janssen, we envision a world without disease Our goal is to use the best internal and external science to transform how diseases are prevented, intercepted, treated, and cured ”
  • Janssen | 2022 Transparency Report
    Through the 2022 Janssen U S Transparency Report, we continue our legacy of contributing insights, data and real-world evidence to help inform and advance policy solutions to create a more sustainable, equitable and innovative healthcare system
  • Acerca de Janssen | Janssen Centro América y Caribe
    En Janssen contribuimos con las comunidades donde operamos Johnson Johnson tiene un programa de responsabilidad social que opera desde 2004 en los diferentes países de
  • A Study of JNJ-78278343, a T-Cell-Redirecting Agent Targeting . . . - Janssen
    A Study of JNJ-78278343, a T-Cell-Redirecting Agent Targeting Human Kallikrein 2 (KLK2), for Advanced Prostate Cancer Last Updated May 14, 2025
  • Janssen
    What You Can Expect To Happen In A Clinical Trial Clinical trials are rarely the same They can last from weeks to years, study different doses of a medication, or even compare multiple medications at once While the details change, all trials are structured in a similar way Typically, there are four main parts of a trial, with each part serving a different purpose
  • Nipocalimab in Moderate to Severe Sjogrens Disease (DAFFODIL)
    This clinical development program for nipocalimab in SjD includes 2 identical double blind, placebo-controlled studies to evaluate the efficacy, safety, and tolerability of nipocalimab in participants greater than or equal to (>=) 18 years of age with moderate to severe SjD
  • Home Fact Group | Janssen Ecuador
    Janssen fue nombrada “Compañía farmacéutica más productiva” por InnoThink Center for Research in Biomedical Innovation
  • Pharmaceutical Company I Janssen Central America and the Caribbean
    Janssen, Pharmaceutical Company of Johnson Johnson, is dedicated to the research and development of innovative therapeutic alternatives in five therapeutic areas, to improve the lives of people in 25 countries in Central America and the Caribbean
  • A Study of JNJ-78278343 in Combination With Either JNJ . . . - Janssen
    The purpose of this study is to identify the recommended phase 2 regimen (s) RP2R (s) of JNJ-78278343 and combination agent in Part 1 (dose escalation) and to determine safety at the putative RP2R (s) of JNJ-78278343 with the combination agent in Part 2 (dose expansion)




Business Directories,Company Directories
Business Directories,Company Directories copyright ©2005-2012 
disclaimer